Luke A. Perry

Luke A. Perry

Auto-generated profile, based on publicly available information

Luke A. Perry

Victorian Cardiac Anaesthesia Research Laboratory, Department of Surgery, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2018 in International Journal of Stroke
Verified
Journal Article
Closed access
LPLuke A Perry
Luke A Perry
TLTom Lucarelli
Tom Lucarelli
JPJahan C Penny-Dimri
Jahan C Penny-Dimri
MMMatthew DF McInnes
Matthew DF McInnes
Stefania MondelloStefania Mondello
Stefania Mondello
BYBernard Yan
Bernard Yan
Glial fibrillary acidic protein (GFAP) has shown promise in several studies for its ability to diagnose intracerebral hemorrhage (ICH). We evaluated the diagnostic accuracy of blood GFAP level to differentiate (ICH) from acute ischemic stroke (AIS) and stroke mimics, both overall, and in the first three hours after symptom onset. We searched multiple databases, without language restriction, from inception until December 2017. Hierarchical summary receiver operating characteristic (HSROC) modeling was used to meta-analyze results. We conducted subgroup analyses restricted to blood samples collected within 0–60, 60–120, and 120–180 min time groups after symptom onset, to evaluate diagnostic accuracy in the early pre-hospital phase. Between and within study heterogeneity was explored using meta-regression. The search identified 199 potentially relevant citations from which 11 studies involving 1297 participants (350 ICH, 947 AIS, or mimic) were included. The pooled sensitivity, specificity, and area under the HSROC curve were 0.756 (95% CI 0.630–0.849), 0.945 (95% CI 0.858–0.980), and 0.904 (95% CI 0.878–0.931), respectively. Differences in assays used, but not the other covariates, partially explained between-study heterogeneity (p = 0.034). The summary estimates for the 0–60, 60–120, and 120–180 min subgroups were comparable to the primary analysis and there was no statistically significant difference in diagnostic accuracy between subgroups. GFAP is a promising diagnostic biomarker for ICH diagnosis in the early pre-hospital phase. Test accuracy is affected by assay subtype, but there are still unexplained sources of heterogeneity. High quality, international multi-center trials are warranted to develop and validate a point-of-care GFAP assay for the rapid triage and evaluation of acute stroke in the pre-hospital setting.

1 May 2022 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
LPLuke A. Perry
Luke A. Perry
ZLZhengyang Liu
Zhengyang Liu
JLJoel Loth
Joel Loth
JPJahan C. Penny-Dimri
Jahan C. Penny-Dimri
MPMark Plummer
Mark Plummer
JSJulian Smith
Julian Smith


25 November 2022 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
JWJoseph Wheatley
Joseph Wheatley
ZLZhengyang Liu
Zhengyang Liu
JLJoel Loth
Joel Loth
MPMark Plummer
Mark Plummer
JPJahan C. Penny‐Dimri
Jahan C. Penny‐Dimri
LPLuke A. Perry
Luke A. Perry
Background: Patients undergoing cardiac surgery are at significant risk of developing postoperative acute kidney injury (AKI). Neutrophil–lymphocyte ratio (NLR) is a widely available inflammatory biomarker which may be of prognostic value in this setting.Methods: We conducted a systematic review and meta‐analysis of studies reporting associations between perioperative NLR with postoperative AKI. We searched Medline, Embase and the Cochrane Library, without language restriction, from inception to May 2022 for relevant studies. We meta‐analysed the reported odds ratios (ORs) with 95% confidence intervals (CIs) for both elevated preoperative and postoperative NLR with risk of postoperative AKI and need for renal replacement therapy (RRT). We conducted a meta‐regression to explore inter‐study statistical heterogeneity.Results: Twelve studies involving 10,724 participants undergoing cardiac surgery were included, with eight studies being deemed at high risk of bias using PROBAST modelling. We found statistically significant associations between elevated preoperative NLR and postoperative AKI (OR 1.45, 95% CI 1.18–1.77), as well as postoperative need for RRT (OR 2.37, 95% CI 1.50–3.72). Postoperative NLR measurements were not of prognostic significance.Conclusions: Elevated preoperative NLR is a reliable inflammatory biomarker for predicting AKI following cardiac surgery.

24 August 2022 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
JPJahan C. Penny‐Dimri
Jahan C. Penny‐Dimri
CBChristoph Bergmeir
Christoph Bergmeir
LPLuke Perry
Luke Perry
LHLinley Hayes
Linley Hayes
RBRinaldo Bellomo
Rinaldo Bellomo
JSJulian Smith
Julian Smith
Machine learning (ML) models are promising tools for predicting adverse postoperative outcomes in cardiac surgery, yet have not translated to routine clinical use. We conducted a systematic review and meta‐analysis to assess the predictive performance of ML approaches. We conducted an electronic search to find studies assessing ML and traditional statistical models to predict postoperative outcomes. Our primary outcome was the concordance (C‐) index of discriminative performance. Using a Bayesian meta‐analytic approach we pooled the C‐indices with the 95% credible interval (CrI) across multiple outcomes comparing ML methods to logistic regression (LR) and clinical scoring tools. Additionally, we performed critical difference and sensitivity analysis. We identified 2792 references from the search of which 51 met inclusion criteria. Two postoperative outcomes were amenable for meta‐analysis: 30‐day mortality and in‐hospital mortality. For 30‐day mortality, the pooled C‐index and 95% CrI were 0.82 (0.79−0.85), 0.80 (0.77−0.84), 0.78 (0.74−0.82) for ML models, LR, and scoring tools respectively. For in‐hospital mortality, the pooled C‐index was 0.81 (0.78−0.84) and 0.79 (0.73−0.84) for ML models and LR, respectively. There were no statistically significant results indicating ML superiority over LR. In cardiac surgery patients, for the prediction of mortality, current ML methods do not have greater discriminative power over LR as measured by the C‐index.

25 August 2020 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PDF file
SJSarah M. Jackson
Sarah M. Jackson
LPLuke A. Perry
Luke A. Perry
CBCarla Borg
Carla Borg
DRDhruvesh M. Ramson
Dhruvesh M. Ramson
RCRyan Campbell
Ryan Campbell
JPJahan Penny-Dimri
Jahan Penny-Dimri
Objective: The global burden of surgical vascular disease is increasing and with it, the need for cost-effective, accessible prognostic biomarkers to aid optimization of peri-operative outcomes. The neutrophil-lymphocyte ratio (NLR) is emerging as a potential candidate biomarker for perioperative risk stratification. We therefore performed this systematic review and meta-analysis on the prognostic value of elevated preoperative NLR in vascular surgery. Methods: We searched Embase (Ovid), Medline (Ovid), and the Cochrane Library database from inception to June 2019. Screening was performed, and included all peer-reviewed original research studies reporting preoperative NLR in adult emergent and elective vascular surgical patients. Studies were assessed for bias and quality of evidence using a standardized tool. Meta-analysis was performed by general linear (mixed-effects) modelling where possible, and otherwise a narrative review was conducted. Between-study heterogeneity was estimated using the Chi-squared statistic and explored qualitatively. Results: Fourteen studies involving 5,652 patients were included. The overall methodological quality was good. Elevated preoperative NLR was associated with increased risk of long-term mortality (HR 1.40 [95%CI: 1.13-1.74], Chi-squared 60.3%, 7 studies, 3,637 people) and short-term mortality (OR: 3.08; 95%CI: 1.91-4.95), Chi-squared 66.59%, 4 studies, 945 people). Outcome measures used by fewer studies such as graft patency and amputation free survival were assessed via narrative review. Conclusions: NLR is a promising, readily obtainable, prognostic biomarker for mortality outcomes following vascular surgery. Heterogeneity in patient factors, severity of vascular disease, and type of vascular surgery performed renders direct comparison of outcomes from the current literature challenging. This systematic review supports further investigation for NLR measurement in pre-vascular surgical risk stratification. In particular, the establishment of a universally accepted NLR cut-off value is of importance in real-world implementation of this biomarker.